EQUILLIUM, INC. Assets, Fair Value Disclosure
EQUILLIUM, INC. (EQ) had Assets, Fair Value Disclosure of $55.88 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-13
- 2026-06-30: Assets, Fair Value Disclosure $55.88M.
- 2026-03-31: Assets, Fair Value Disclosure $60.39M.
- 2025-12-31: Assets, Fair Value Disclosure $29.73M.
- 2025-09-30: Assets, Fair Value Disclosure $32.42M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $55.88M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $60.39M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $29.73M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $32.42M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $10.27M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $13.14M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $18.95M 10-K · filed 2026-03-25 | $37.55M 10-K · filed 2025-03-27 |
| 2023-12-31 | $18.95M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |